Healthcare & Life SciencesReported founding year: 2013~22 peopleBoston, MA, USA
Next-generation mRNA platform to solve cancer, COVID and climate.
Technology finds information and delivers physical products to us almost instantly. mRNA does the same for biology. At HelixNano, we see a world where treatments are cheap, progress is decentralized, and you can modify biology at the push of a button.
By focusing on mRNA improvements from first principles, we’re getting there faster than we thought. Experiments that used to take months or years can be done in weeks and cost thousands instead of millions. The rate limiting step for our progress is now scientific curiosity.
Rigid hierarchies and top-down decisions will miss the magic. Some of our most powerful technologies started out as side projects of junior team members. At HelixNano, every individual scientist can have a massive impact on the company's direction. And the more diverse our team, the faster we’ll find the really cool ideas.
We've started rolling out some of our new tech — moving a COVID-19 vaccine candidate for the immunocompromised towards the clinic, and testing an intervention with massive environmental impact. But we’re scientists at heart, and team focus is solidly on the horizon.
Pressurl: https://news.google.com/rss/articles/CBMiqgFBVV95cUxQNXhwZlhtc25Db21JSEJyTFBXcGVGZnF5NHJnTWVoZUQxRmxaZExxLUtSUm4xVnRtWjBRZmdyZlFKd0V1b1ptakJub2JZX3AxRXhFOGFQTlJiQUNWSTZuS3JxcDQ5OVppcDB2SW9GQ0VHakYxelZsVVpqblJkQWhXR3FnYThSMmlvc0I3b3E4eGl4SWlNbEdod3JhQlRpdXI5WmFvQl83U2VrQdIBrwFBVV95cUxOS3lRY1lHQ2I1dW1oYWRzYkoxdnhsbE9VT0lYM01IRmtKd1piODlTbFlmX0VDNk9NNzdQX1A4VFdJNmtvdVcycUhrRlEtRHgzWXZ2WDhzMGJWOEhveUtlek85Uzk2SnhFVExXVVltVHhWTlQ4R19RY1NOSkpjX050cXVsN3pSMlN0bGpWYkNMMmprVEdDTm05VS11YUZsVUF3bmxyZDExSlQ5UWtzR1ZZ?oc=5 · headline: This biotech start-up is working overtime to develop a second-wave, mutation-resistant Covid-19 vaccine · publication: CNBCgoogle_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiqwFBVV95cUxOMVNIZEROU2k2eWFzZDdGVGJwM2N5aWtLOXdIdzZhM1ZEbDBzUnJuNVRRY2xQSHhDU09ieHJzUDRQQmVJYzZYQWlKODhEai1pV05aRDVOOTk2bnVjNHBvenl1dGtpX0lRenNBN2lCU3lEWnlPbUdCZy1jQy1tMUV5cjU5c1laNFBLbnctTFFMbmRXUXdtVVUxVVpuQ2IxdVYybmRIVGNSQ0NkMmc?oc=5 · headline: Plural lures mRNA vaccine and AI pioneer to become its newest partner · publication: TechCrunchgoogle_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMingFBVV95cUxNYV8tV09WWVhWcEFHUWQzdzlfcnNCXzQ4U0xsWDBPZjI0NWw0ZHBqTkVxYlhvOXdHOXExbjgzblAxUUVpOFpOcnFZdHhHMlNidV9SRTNwRHo1ckZtSmNma3JjQW5rdnE4VmctWkJ1NzBNcTl1Qm40Ymtrd0VadFNTdHZGZnZvbkZhN1B3RHBmZkJQb0M2N0VxWmUxNmNOQdIBowFBVV95cUxNTlpvWEhvNzQtay13cVFZZUdMWmp0U3NGaFRENnN3M0dmQUlHTDhnQlkwc0U3V2ZVRGdYVzJhR3YxczJ5UEYwSHNpZXhLaXBQdHhQZ3pKb0xKZ3lZNlNSbS00Y1VuMHFQengxZHZ3M2xRQmo1c1lmWkVOQU9aV2dGZDBNY212MHNOTmtBWGRmLVpMMDBOb0E2dndDdGwtR0l1UGRn?oc=5 · headline: What it's like to invent a coronavirus vaccine in the middle of a pandemic · publication: CNBCgoogle_news · 9/15/2026
Press
What it's like to invent a coronavirus vaccine in the middle of a pandemic
url: https://news.google.com/rss/articles/CBMiZEFVX3lxTE5ka05rN1hDbktud1lIcUVrNUdPX0lwRTBOTEZSWU5aVjVUcS15V3ZNbGsxUVRrbWpkRkczR3FzYXFmNnVtSGxneERCdHoxeWkxTlh6dWFHWFJNMHBGZ1ZuSUpjYnI?oc=5 · headline: Helix Nanotechnologies · publication: The Pharma Letter
google_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMilAFBVV95cUxNcVZjdFdUbGRTVDlnOFdrSWJTbWZwcmRlaXZQcDBNNDFqQllUZkRzVGtxaGxJNnBPZXpkQWsxMmlXMjdFZjB3ai0tRnRxSFI2eG84UXM1aTh5VzJhRTVFckM4d05FSnFkX3JtRnVtVmtBMU1CY2hvVk1XSkJWdmRtTXFQREhnaWR1bG1wdS1CYUEtem1L?oc=5 · headline: OpenAI leads $15 million seed in Red Queen Bio for AI biosecurity · publication: techinformed.comgoogle_news · 9/15/2026